Cory A H, Samano V, Robins M J, Cory J G
Department of Biochemistry, East Carolina University, School of Medicine, Greenville 27858.
Biochem Pharmacol. 1994 Jan 20;47(2):365-71. doi: 10.1016/0006-2952(94)90028-0.
The 2'-deoxy-2'-methylene derivatives of adenosine (MdAdo), guanosine (MdGuo), tubercidin (MdTu), cytidine (MdCyd) and uridine (MdUrd) were synthesized as mechanism-based inhibitors directed at ribonucleotide reductase. It was shown that MdCyd 5'-diphosphate irreversibly inactivated ribonucleotide reductase from Escherichia coli (Baker et al., J Med Chem 34: 1879-1884, 1991). In studies reported here, MdAdo/EHNA, MdGuo and MdCyd inhibited L1210 cell growth with IC50 values of 3.4, 10.6 and 1.4 microM, respectively. Since MdAdo is a substrate for adenosine deaminase, the presence of EHNA was required to give maximal growth inhibition. 8-Aminoguanosine was not required to maximize the cytotoxic effects of MdGuo. The 2'-deoxy-2'-methylene derivatives of tubercidin and uridine did not inhibit L1210 cell growth at concentrations as high as 50 microM (MdTu) or 100 microM (MdUrd). L1210 cell lines resistant to hydroxyurea (directed at the non-heme iron subunit of ribonucleotide reductase) or deoxyadenosine (directed at the effector binding subunit of ribonucleotide reductase) were not resistant to MdCyd. An L1210 cell line that was highly resistant to dGuo due to the loss of a relatively specific deoxyribonucleoside kinase (Cory et al., J Biol Chem 268: 405-409, 1993) had a 6.6-fold increase in the IC50 value toward MdCyd, but showed only a 2-fold increase in resistance to MdGuo. Another L1210 cell line that was markedly deficient in adenosine kinase activity was highly resistant to MdAdo. Analysis by flow cytometry showed that MdCyd showed the transit of the cells through the G2/M phase of the cell cycle resulting in the buildup of the G2/M population. MdAdo, MdGuo and MdCyd inhibited the incorporation of [14C]cytidine into DNA without an effect on RNA synthesis or total cellular uptake of [14C]cytidine. The conversion of [14C]cytidine to deoxycytidine nucleotides was partially inhibited by MdGuo, but not by MdAdo or MdCyd. These data show that the 2'-deoxy-2'-methylene derivatives of adenosine, guanosine and cytidine are activated via specific nucleoside kinases and that the modes of action of these compounds are not identical.
合成了腺苷(MdAdo)、鸟苷(MdGuo)、杀结核菌素(MdTu)、胞苷(MdCyd)和尿苷(MdUrd)的2'-脱氧-2'-亚甲基衍生物,作为针对核糖核苷酸还原酶的基于机制的抑制剂。已表明MdCyd 5'-二磷酸不可逆地使大肠杆菌的核糖核苷酸还原酶失活(Baker等人,《药物化学杂志》34: 1879 - 1884,1991)。在本文报道的研究中,MdAdo/EHNA、MdGuo和MdCyd抑制L1210细胞生长,IC50值分别为3.4、10.6和1.4微摩尔。由于MdAdo是腺苷脱氨酶的底物,需要存在EHNA才能产生最大生长抑制作用。8 - 氨基鸟苷对于使MdGuo的细胞毒性作用最大化并非必需。杀结核菌素和尿苷的2'-脱氧-2'-亚甲基衍生物在浓度高达50微摩尔(MdTu)或100微摩尔(MdUrd)时不抑制L1210细胞生长。对羟基脲(针对核糖核苷酸还原酶的非血红素铁亚基)或脱氧腺苷(针对核糖核苷酸还原酶的效应物结合亚基)耐药的L1210细胞系对MdCyd不耐药。由于相对特异性的脱氧核糖核苷激酶缺失而对dGuo高度耐药的L1210细胞系对MdCyd的IC50值增加了6.6倍,但对MdGuo的耐药性仅增加了2倍。另一个腺苷激酶活性明显缺乏的L1210细胞系对MdAdo高度耐药。通过流式细胞术分析表明,MdCyd使细胞通过细胞周期的G2/M期,导致G2/M期细胞群体积累。MdAdo、MdGuo和MdCyd抑制[14C]胞苷掺入DNA,而对RNA合成或[14C]胞苷的总细胞摄取无影响。[14C]胞苷向脱氧胞苷核苷酸的转化被MdGuo部分抑制,但不被MdAdo或MdCyd抑制。这些数据表明,腺苷、鸟苷和胞苷的2'-脱氧-2'-亚甲基衍生物通过特定的核苷激酶被激活,并且这些化合物的作用模式并不相同。